Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Cognizant plans to hire 1,500 U.S. college graduates and scale a new Frontier Certified Engineer and Frontier Business Operator workforce to 15,000 people.
Ascendis Pharma will present data from its pivotal reACHin Trial of TransCon CNP (navepegritide) in infants with achondroplasia aged 0 to <2 years at ESPE 2026.
Novo Nordisk's STEP Young phase 3 trial met its primary endpoint, showing 40.4% of children aged 6 to under 12 with obesity achieved a BMI below the obesity threshold after 68 weeks of semaglutide treatment.
Insilico's AI-designed drug rentosertib showed potential for biological age reversal in a Phase IIa trial for idiopathic pulmonary fibrosis (IPF), as assessed by six proteomic aging clocks.
Smart City Expo World Congress 2026 will take place from November 3 to 5 in Barcelona, featuring 1,000 cities, 25,000 attendees, 1,000 exhibitors, and 600 speakers.
The Asia-Pacific Media Forum opened in Shenzhen on September 5, 2026, with over 400 representatives from 220+ media organizations, think tanks, and government agencies from 42 countries.
